$305.71
+9.01 (+3.04%)
Performance
1D
—
1W
—
1M
—
3M
+12.14%
6M
+50.60%
1Y
+119.26%
YTD
+23.81%
Open$297.00
Previous Close$296.70
Day High$306.10
Day Low$292.00
52W High$303.00
52W Low$122.80
Volume—
Avg Volume326.4K
Market Cap8.75B
P/E Ratio42.70
EPS$6.84
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$263.07
Above
SMA 200
$186.47
Above
RSI (14)
38.4
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
18 analysts
Price Target
-71.6% upside
Current
$305.71
$305.71
Target
$86.77
$86.77
$54.31
$86.77 avg
$114.95
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 371.72M | 971.92M | 894.90M |
| Net Income | 195.67M | 120.52M | 102.54M |
| Profit Margin | 52.6% | 12.4% | 11.5% |
| EBITDA | 159.55M | 242.82M | 232.68M |
| Free Cash Flow | — | 82.52M | 69.44M |
| Rev Growth | — | +7.7% | -5.6% |
| Debt/Equity | — | 0.59 | 0.54 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |